Biologics/Immunotherapy News

Patients with atopic dermatitis and moderate to severe ocular surface disease who were treated with dupilumab had higher levels of the biologic in their tears than those with mild or no ocular surface disease, according to study results.

Adolescents with severe peanut allergy experienced clinically relevant improvements in health-related quality of life with oral immunotherapy and omalizumab, according to a letter published in Clinical and Translational Allergy.

Adults who were taking dupilumab for their atopic dermatitis also experienced significant improvements in their mild asthma, primarily in the first 16 weeks, according to a study published in Clinical and Translational Allergy.

Real-world patterns of peanut oral immunotherapy treatment showed high persistence and rare modification among a demographically diverse group of children, according to a study published in Annals of Allergy, Asthma & Immunology.

Despite the potential for both allergic and nonallergic reactions, researchers did not find evidence for an association between levels of anxiety and oral immunotherapy treatment for peanut allergy in children, according to study results.

Change is far from incremental in allergy and asthma care based on the speakers and presentations scheduled for the American Academy of Allergy, Asthma & Immunology Annual Meeting in San Antonio from Feb. 24 to 27.

Children with atopic dermatitis who received dupilumab experienced improvements in disease severity and decreases in severity-associated serum biomarkers, according to a study published in Pediatric Allergy and Immunology.

The FDA has approved tezepelumab-ekko for self-administration in a prefilled, single-use pen among patients aged 12 years and older with severe asthma, according to a press release from the manufacturer.

Children and adolescents on peanut OIT may experience anaphylaxis during the up-dosing and maintenance stages, often caused by avoidable triggers, according to a study published in Pediatric Allergy and Immunology.

Healio compiled the most-read news in allergy, asthma and immunology posted in January.